These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4930644)

  • 1. [Angiographic follow-up examination findings in arteriosclerosis obliterans with and without long-term anticoagulant therapy].
    Schmidt KH; Schmidt H; Heine H; Porstmann W; Driese H
    Dtsch Gesundheitsw; 1971 Feb; 26(8):346-9. PubMed ID: 4930644
    [No Abstract]   [Full Text] [Related]  

  • 2. Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy.
    Tillgren C
    Acta Med Scand; 1965 Aug; 178(2):203-19. PubMed ID: 4158084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term use of indirect anticoagulants in patients with obliterating atherosclerosis of peripheral arteries].
    Khaĭne Kh; Norden K; Makh Kh; Shmidt Kh
    Kardiologiia; 1985 Sep; 25(9):61-3. PubMed ID: 3908781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Angioprotective activity of mexicor in atherosclerosis obliterans of the lower limbs].
    Inchina VI; Smirnov LD; Romanov MD; Kokoreva EV; Morozov MIu
    Angiol Sosud Khir; 2007; 13(3):17-20. PubMed ID: 18382390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of anticoagulants in obliterative arterial disease of the legs.
    Tillgren C; Lund F
    Scand J Clin Lab Invest Suppl; 1967; 99():184-6. PubMed ID: 6056920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Personal experience on indirect long-term anticoagulant therapy in ambulatory peripheral chronic arteriosclersis obliterans patients].
    Raso AM; Silvestrini P
    Angiologia; 1968; 20(6):301-16. PubMed ID: 5747170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a long-term anticoagulant therapy in patients with arteriosclerosis obliterans compared to a collective group with myocardial infarct].
    Schmidt HH; Heine H; Zimmermann B; Hackenberger F
    Z Gesamte Inn Med; 1971 Oct; 26(20):Suppl 20:275-7. PubMed ID: 5004145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems in the use of anticoagulants in severe arterial occlusive diseases of the limbs].
    Linke H
    Z Gesamte Inn Med; 1970 Aug; 25(15):688-93. PubMed ID: 5527533
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin and exercise treatment in a patient with arteriosclerosis obliterans.
    Shioji K; Fujita M; Yamada T; Matsuda T; Nohara R; Sasayama S
    Jpn Circ J; 1997 Aug; 61(8):715-8. PubMed ID: 9276778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diprophyllinum prolongatum (Polfa, Cracow) in the treatment of arteriosclerosis obliterans of the lower limbs].
    Kostka-Trabka E; Grodzińska L; Dembińska-Kieć A; Basista M; Telesz E
    Przegl Lek; 1983; 40(7):563-6. PubMed ID: 6356236
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the differential diagnosis of arterial obliterating diseases of the upper extremities].
    Hofmeister L
    Munch Med Wochenschr; 1969 May; 111(22):1259-64. PubMed ID: 5819096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L
    Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract]   [Full Text] [Related]  

  • 14. [Arteriosclerosis: a challenge for the surgeon. Prevention and postoperative care (author's transl)].
    Rau G
    Langenbecks Arch Chir; 1975 Nov; 339():175-85. PubMed ID: 1207298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
    Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical rheovasographic comparisons in arteriosclerosis obliterans of the lower extremities].
    Akhverdian RA; Nagapetian IO
    Zh Eksp Klin Med; 1972; 12(4):76-83. PubMed ID: 4668897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
    Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Bieroń K; Kedzior A; Basista M; Zmuda A; Trabka E; Sławiński M; Czarnecka B
    Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1643-8. PubMed ID: 3330798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between roentgenologic bone changes and some indices of the functional state of blood vessels in patients with arteriosclerosis obliterans of the lower extremities].
    Kasparian RM
    Zh Eksp Klin Med; 1971; 11(1):66-74. PubMed ID: 5096749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.